Skip to main content
. 2020 May 29;11:814. doi: 10.3389/fphar.2020.00814

Figure 2.

Figure 2

SLBZS ameliorates DSS-induced colonic inflammatory symptoms in mice. (A) The experimental scheme of SLBZS treatment in DSS-induced colitis in mice. (B) Body weight (n = 10). (C) Representative picture of the colon. (D) Colon length (n = 10). (E) DAI reflecting weight loss scores, fecal status scores, and bloody stool scores, assessed every day. (F, G) Routine blood tests for the number of PLTs and WBCs in the serum of mice. (H) Representative image of mouse colon stained with H&E (×100). The data are shown as the mean ± S.E.M. #P < 0.05, ##P < 0.01 vs. the control group; *P < 0.05, **P < 0.01 vs. the model group.